CAR T-cell therapy is giving hope to cancer patients around the world.
But it's not available in New Zealand, either through the public or private system, meaning patients who have exhausted their options through traditional therapies need to head overseas and pay hundreds of thousands of dollars for the treatment.
Dr Robert Weinkove is clinical director at Wellington's Malaghan Institute where they are running a clinical trial. He talks to Emile about the potential of CAR T-cell therapy.
Dr Robert Weinkove Photo: Malaghan Institute
